A | B | C | D | E | F | G | H | CH | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9
LPD-824
...Chemical compound
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "LPD-824" – news · newspapers · books · scholar · JSTOR (December 2009) (Learn how and when to remove this template message) |
Clinical data | |
---|---|
Other names | LPD-824, N-Pyrrolidyl-lysergamide |
Routes of administration | Oral |
Pharmacokinetic data | |
Metabolism | Hepatic |
Excretion | Renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C20H23N3O |
Molar mass | 321.424 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
N-Pyrrolidyllysergamide (LPD-824) is a derivative of ergine. It is reported to have some mild, short lasting LSD-like effects at a dose of 800 micrograms.[1]